132 related articles for article (PubMed ID: 32810510)
1. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line.
Kumari N; Bhargava A; Rath SN
Life Sci; 2020 Nov; 260():118291. PubMed ID: 32810510
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel.
Kumari N; Dalal V; Kumar P; Rath SN
J Biomol Struct Dyn; 2022 Apr; 40(6):2395-2406. PubMed ID: 33103598
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel.
Kumari N; Giri PS; Rath SN
Cancer Drug Resist; 2021; 4(4):996-1007. PubMed ID: 35582374
[No Abstract] [Full Text] [Related]
4. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
5. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
Cazade M; Nuss CE; Bidaud I; Renger JJ; Uebele VN; Lory P; Chemin J
Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
[TBL] [Abstract][Full Text] [Related]
6. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
[TBL] [Abstract][Full Text] [Related]
7. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
Sakkaki S; Gangarossa G; Lerat B; Françon D; Forichon L; Chemin J; Valjent E; Lerner-Natoli M; Lory P
Neuropharmacology; 2016 Feb; 101():320-9. PubMed ID: 26456350
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of curcumin on human lung adenocarcinoma LTEP-A2 cells and its mechanism.
Mingao Z; Lei C
Pak J Pharm Sci; 2019 May; 32(3 Special):1307-1311. PubMed ID: 31551208
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist.
Choi DL; Jang SJ; Cho S; Choi HE; Rim HK; Lee KT; Lee JY
Bioorg Med Chem Lett; 2014 Mar; 24(6):1565-70. PubMed ID: 24529871
[TBL] [Abstract][Full Text] [Related]
10. T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats.
Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Nguyen SJ; Surles NO; Yao L; Barrow JC; Uebele VN; Renger JJ; Clark J; Hutson PH
Neuropharmacology; 2012 Mar; 62(3):1413-21. PubMed ID: 21110986
[TBL] [Abstract][Full Text] [Related]
11.
Pu J; Shen J; Zhong Z; Yanling M; Gao J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):639-647. PubMed ID: 32064933
[TBL] [Abstract][Full Text] [Related]
12. The effects of preferential A- and C-fibre blocks and T-type calcium channel antagonist on detection of low-force monofilaments in healthy human participants.
Nagi SS; Dunn JS; Birznieks I; Vickery RM; Mahns DA
BMC Neurosci; 2015 Aug; 16():52. PubMed ID: 26268809
[TBL] [Abstract][Full Text] [Related]
13. T-type Ca2+ channel blocker, KYS05047 induces G1 phase cell cycle arrest by decreasing intracellular Ca2+ levels in human lung adenocarcinoma A549 cells.
Rim HK; Lee HW; Choi IS; Park JY; Choi HW; Choi JH; Cho YW; Lee JY; Lee KT
Bioorg Med Chem Lett; 2012 Dec; 22(23):7123-6. PubMed ID: 23079520
[TBL] [Abstract][Full Text] [Related]
14. The Hard-To-Close Window of T-Type Calcium Channels.
Visa A; Shaikh S; Alza L; Herreros J; Cantí C
Trends Mol Med; 2019 Jul; 25(7):571-584. PubMed ID: 31031178
[TBL] [Abstract][Full Text] [Related]
15. Rose (
Lim WC; Choi HK; Kim KT; Lim TG
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158043
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ca
Picard E; Carvalho FA; Agosti F; Bourinet E; Ardid D; Eschalier A; Daulhac L; Mallet C
Br J Pharmacol; 2019 Apr; 176(7):950-963. PubMed ID: 30714145
[TBL] [Abstract][Full Text] [Related]
17. T-type Ca
Sankhe S; Manousakidi S; Antigny F; Arthur Ataam J; Bentebbal S; Ruchon Y; Lecerf F; Sabourin J; Price L; Fadel E; Dorfmüller P; Eddahibi S; Humbert M; Perros F; Capuano V
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1631-1641. PubMed ID: 28655554
[TBL] [Abstract][Full Text] [Related]
18. T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells.
Silvestri R; Pucci P; Venalainen E; Matheou C; Mather R; Chandler S; Aceto R; Rigas SH; Wang Y; Rietdorf K; Bootman MD; Crea F
Prostate; 2019 Sep; 79(13):1580-1586. PubMed ID: 31334879
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
20. Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy.
Santoni G; Santoni M; Nabissi M
Br J Pharmacol; 2012 Jun; 166(4):1244-6. PubMed ID: 22352795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
